Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis - Wikidata - awgldk - TriplyDB

Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis

Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis

http://www.wikidata.org/entity/Q34777465

about

Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)The innate immune system in demyelinating disease Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair Remyelination Therapy in Multiple Sclerosis Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs IL-17 family: cytokines, receptors and signaling Multiple sclerosis: the role of cytokines in pathogenesis and in therapies The inflammasome pyrin contributes to pertussis toxin-induced IL-1β synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis What we know and do not know about the cannabinoid receptor 2 (CB2)Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications Control of autoimmune CNS inflammation by astrocytes The astrocyte in multiple sclerosis revisited The IL-17 pathway as a major therapeutic target in autoimmune diseases Macrophages participate in IL-17-mediated inflammation Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: a case-control study of rapidly progressive dementia Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells.Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases.Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression Myelin recovery in multiple sclerosis: the challenge of remyelination Chemokine receptor expression by inflammatory T cells in EAE.The flavonoid cyanidin blocks binding of the cytokine interleukin-17A to the IL-17RA subunit to alleviate inflammation in vivo.Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling.The differential regulation of human ACT1 isoforms by Hsp90 in IL-17 signaling An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-culture.The role of antigen presenting cells in multiple sclerosis.SOCS3 deficiency promotes M1 macrophage polarization and inflammation.Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling.Interleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzyme.IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disability The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis Interleukin-17 enhances immunosuppression by mesenchymal stem cells Roles of Toll-like receptor 2 (TLR2) and superantigens on adaptive immune responses during CNS staphylococcal infection.CNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia.IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms

P2860

Q24319867-4F534819-8610-4891-9A5D-60168EA47E22 Q24597958-0AD18F11-4583-41C2-9677-685A30341795 Q26739719-4363C42F-6E18-4735-BAC0-4EF1EF157101 Q26772359-00C52F9D-9193-4358-8C9E-2DF7314930E7 Q26799975-55E23A7B-A622-4287-913F-5D9B1C09FD81 Q26860251-372928B4-620B-407F-9F8D-C9D568D1CC3D Q27011014-D840ED1E-3AAD-426B-A4DE-00A81AEC1BD6 Q27325503-FCC3CAF1-6D8D-43FB-865D-ABBE3F32ADA9 Q27686851-CA339CDF-56A8-4131-B39D-ADA6A0EDA944 Q28067738-59B5DA9A-A4DD-4E85-A519-FF89CA73F2F7 Q28073377-F5D67113-014F-489F-A23E-D270EDA24546 Q28078299-BD9B781D-CD53-45A1-9B73-8D13B61D87C8 Q28084132-9E3D278A-AE13-49EA-9B46-5C0304AD0CC9 Q28283441-A2CD9B24-D6BA-40B4-80E5-7BC9D2F34A4F Q28300826-D2DC0D72-62D7-4ADD-AC63-14D42BB34690 Q28652293-45FC84B0-202A-499D-9E18-D59AED800D37 Q30426405-EB0DD541-C905-474B-ADBA-AE94F3DEE7A4 Q30574747-9F5AED8C-AD95-4656-AF96-208B91FFECD6 Q30724821-B8238DD5-29D5-4BB0-A26D-F56F53545C8E Q33569870-DB3F9CD5-710E-41BE-BC65-12BD0D5F3A9C Q33761191-E9B7B0C9-8304-4A18-AEB9-0DF40236DCC3 Q33766764-CDE5D659-C566-4A0C-A3EC-32C97997CC2D Q33772195-F5108EB8-6BA5-4983-9C01-04E8AC566A0C Q33846596-FB960891-AF67-4448-99BA-834BFF2B1AD8 Q33922498-9E3E38A8-D7F4-4D35-84AB-AED5D6783F2E Q33930062-CAE0692C-F49B-4A2C-B6E6-B1445F4431A0 Q33963074-2754E7D5-52F6-47A9-B90E-3029D9BBF94D Q33964282-8DA2423D-1613-4CA2-9FA6-341D1B21A688 Q33992530-0E985E0D-D731-42FE-90F5-C894539C37E1 Q34004601-02722271-3FAE-44A8-A5C9-4104FE3799C4 Q34268029-786D36B2-53BC-42C0-B7EB-8BD327EAC0F8 Q34287544-3D6C4CF7-5500-4762-9D61-134031B48D0C Q34340648-8798C513-328B-4DA1-AF6F-00EB94909D0E Q34355656-6D7BCA38-9633-4DEE-BA97-C2AAB8B61A35 Q34359503-CDD8F786-F89C-4A59-A81E-80A641DE77CA Q34413247-7304C837-3987-4B43-B6B7-E6E1ED63F56F Q34413472-01BD65FA-3348-4B60-A13E-F62EFAE39E58 Q34507688-CD459851-6C9D-47AA-9450-BD40C2F02FB6 Q34611991-380C06EB-15BE-4264-A2C7-2E1ACF405DC7 Q34787020-230719FA-433A-4EDD-8A00-05F04C30480D

P2860

Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis

http://www.wikidata.org/entity/Q34777465

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Astrocyte-restricted ablation ...... s autoimmune encephalomyelitis

@ast

Astrocyte-restricted ablation ...... s autoimmune encephalomyelitis

@en

Astrocyte-restricted ablation ...... s autoimmune encephalomyelitis

@nl

type

label

Astrocyte-restricted ablation ...... s autoimmune encephalomyelitis

@ast

Astrocyte-restricted ablation ...... s autoimmune encephalomyelitis

@en

Astrocyte-restricted ablation ...... s autoimmune encephalomyelitis

@nl

prefLabel

Astrocyte-restricted ablation ...... s autoimmune encephalomyelitis

@ast

Astrocyte-restricted ablation ...... s autoimmune encephalomyelitis

@en

Astrocyte-restricted ablation ...... s autoimmune encephalomyelitis

@nl

P1433

Q34777465-31AF07F4-25F0-4B4F-8331-30478AF0F237

P1476

Q34777465-CFA3A5D7-C140-4346-985C-13B416887E28

P2093

Q34777465-1E8B157D-05D8-46AE-9848-9FCBBB06284E

Q34777465-23033C16-4CEB-4473-A5A1-821917F77B50

Q34777465-396F3F17-267F-491A-BAA0-ABB3B29FA9AE

Q34777465-61BFD036-EE71-4E21-B42B-9740CD7F95C2

Q34777465-65C7D4C2-5AF2-4A7A-A49D-93FB0FF9B3DB

Q34777465-69D8D763-50E9-4736-826B-9FDD808BE54A

Q34777465-9BAB7178-3895-479D-9781-30F81D910149

Q34777465-9F36CFA3-17D2-437D-A843-204ADEB401F0

Q34777465-B6F07824-F345-42C4-8ECE-610486D6F694

Q34777465-BDF327FC-7002-41D3-8305-00380DFE25E8

P2860

Q34777465-00B8576E-864C-4BA1-976C-5572226E1D5F

Q34777465-05100C72-C30C-464E-9742-C6AF9B2D9469

Q34777465-06EC36F8-DFF0-4993-84B8-C0B49E6B7406

Q34777465-0B80E4CE-5318-421C-BA32-C9B0DF5D9048

Q34777465-0BA4FAEB-9504-4836-9A67-FC1EAE5970E8

Q34777465-0C952885-149C-4D30-92D6-E3D7B3162978

Q34777465-0CB392C9-E6BF-45E2-9D0E-B597B5723989

Q34777465-0F297569-8B11-472C-84A4-51FC5F7A054E

Q34777465-10ED6AF0-B954-4033-9988-2819F6F5BFBB

Q34777465-12F197C0-A380-4F75-B9BD-06DF0F43AABA

P304

Q34777465-9DEE926B-8C40-4DE5-9DA8-03D989AB995F

P31

Q34777465-9585ED94-7FDF-46D7-9BE0-64DD12A0AAAA

P356

Q34777465-2A011781-5AB0-4234-BE55-65512B7FB7E0

P407

Q34777465-7610ED9A-C5DB-4CBC-911B-FCC75F218310

P433

Q34777465-D24130B2-806B-4184-8B9A-1BDEFB316246

P478

Q34777465-F9DCDBE8-BD3F-4474-8FA0-BABC02962E05

P50

Q34777465-2EFEA635-0C9E-4BCC-9B8C-5FA5D3F1ED1D

P577

Q34777465-DB1B09AF-C2AD-4C58-BA79-6C3A0119227F

P5875

Q34777465-C42BDF04-131E-458C-AAA3-6670DB2F9B3E

P698

Q34777465-D2787577-735A-486C-9278-3F104512B139

P921

Q34777465-cd18675e-d1aa-4ab1-a734-fe2e8d4e8f54

Q34777465-e84096c9-a422-4361-9214-6f83ed7f815e

P932

Q34777465-A1EA4510-7E89-46E1-A153-6B5F21F4B4F8

P356

J.IMMUNI.2010.03.004

P1433

P1476

Astrocyte-restricted ablation ...... s autoimmune encephalomyelitis

@en

P2093

Caini Liu

http://www.w3.org/2001/XMLSchema#string

Cengiz Zubeyir Altuntas

http://www.w3.org/2001/XMLSchema#string

Hongwei Qin

http://www.w3.org/2001/XMLSchema#string

Liping Liu

http://www.w3.org/2001/XMLSchema#string

Muhammet Fatih Gulen

http://www.w3.org/2001/XMLSchema#string

Natalia Giltiay

http://www.w3.org/2001/XMLSchema#string

Richard M Ransohoff

http://www.w3.org/2001/XMLSchema#string

Stephen Stohlman

http://www.w3.org/2001/XMLSchema#string

Vincent K Tuohy

http://www.w3.org/2001/XMLSchema#string

Wen Qian

http://www.w3.org/2001/XMLSchema#string

P2860

CIKS, a connection to Ikappa B kinase and stress-activated protein kinase

Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells

Act1, an NF-kappa B-activating protein

IL-17 and Th17 Cells

Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation

Transforming growth factor-beta induces development of the T(H)17 lineage

Cutting edge: interleukin 17 signals through a heteromeric receptor complex

Interleukin-17 family members and inflammation

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

Act1, a negative regulator in CD40- and BAFF-mediated B cell survival

P304

414-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2010.03.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Cornelia C. Bergmann

P577

2010-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42370256

http://www.w3.org/2001/XMLSchema#string

P698

20303295

http://www.w3.org/2001/XMLSchema#string

P921

P932

3073618

http://www.w3.org/2001/XMLSchema#string